In episode 273, Mike and James break down even more evidence around treatments for osteoarthritis. In this episode, we discuss topical NSAIDs, alternative therapies, narcotics and conclude, as in the previous podcast, that it is ultimately up to the patient to try to figure out what works best for them.
Show notes
In episode 272, Mike and James break down all the evidence around treatments for osteoarthritis. In this episode, we discuss activity, acetaminophen, NSAIDs and the benefits and harms around these treatments and at the end we come to the conclusion that it is ultimately up to the patient to try to figure out what works best for them.
Show notes
In episode 271, James and Mike discuss the most recent evidence for two new monoclonal antibody medications that lower lipids. We discuss the two new studies OSLER and ODYSSEY. At the end we both agree that it is great these studies looked at cardiovascular events and at least they are going in the right direction. However, we still have a long way to go before we would consider using them.
Show notes
Study synopses can be found at mystudies.org
DESCARTES
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
OSLER
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
ODYSSEY LONG TERM
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
THE NUTRITION PROPOSITION BOOK
Check it out at nutritionproposition.com and think about picking up a copy on Amazon. All the evidence you ever wanted about nutrition and the only nutrition book that won’t tell you what to eat.
This pragmatic trial is now recruiting in BC. Make a difference and get involved with pragmatic trials (www.pragmatictrials.ca)
